Aim To explore the antiangiogenic property of isoliquiritigenin (ISL) on in vivo and in vitro models. Design Laboratory investigation. Methods The effect of ISL on angiogenesis development was investigated using ex ovo chick chorioallantoic membrane model. Its effect on pathological angiogenesis was examined by (1) silver nitrate cauterisation-induced corneal neovascularisation in BALB/c mice, followed by topical ISL (0.2e50 mM) and CD31 immunofluorescence of corneal blood vessels; (2) argon laser photocoagulation-induced choroidal neovascularisation in C57BL/6 mice, followed by intravitreal ISL (10e200 mM) and fundus fluorescein angiography and immunofluorescence with Griffonia simplicifolia isolectin-B4 (GSA I-B4); and (3) oxygen-induced retinopathy in C57BL/6J mice pups, followed by intravitreal ISL (1e100 mM) and GSA I-B4 immunofluorescence. The vascular area was quantified and analysed by one-way analysis of variance and Student t test. Expression of vascular endothelial growth factor (VEGF) and pigmentepithelium-derived factor in human umbilical vein endothelial cells was analysed by western blotting.
INTRODUCTION
Pathological ocular neovascularisation (NV) is known to be associated with major eye diseases in the anterior as well as posterior segments.
1e5 Both corneal and choroidal NV, secondary to age-related macular degeneration, constitute a significant cause of ocular morbidity and visual loss. 1 The majority of the present-day antiangiogenic agents are targeted against the vascular endothelial growth factor (VEGF) owing to its implication in the pathogenesis of angiogenesis. 1 5 Although effective in cases with age-related macular degeneration, such treatments are expensive and require repeated injections and therefore confer risk of endophthalmitis. As for corneal NV, several antiangiogenic molecules such as angiostatin and angiostatin-like fragments have been tested. 6e8 Endostatin (a proteolytic fragment of collagen XVIII) suppressed basic fibroblast growth-factor-induced angiogenesis in corneal pocket assays. 9 10 Isoliquiritigenin (ISL) is a natural flavonoid isolated from the root of licorice (Glycyrrhiza uralensis). Licorice extract and its components have been known for their antioxidative, anti-inflammatory and apoptosis-promoting activities in cancers, granulomas and normal tissues.
11e20 Very recently, PHY906, a four-herb Chinese medicine formula with licorice as a major ingredient, was shown to reduce chemotherapy-induced toxicity in a phase I/II clinical study. 21 ISL was reported to inhibit phorbol myristate acetate-triggered endothelial cell migration and tube formation through suppression of matrix metalloproteinase (MMP-2) and membrane-type MMP. 19 From the chemical structureeactivity prediction, ISL could have a greater antiangiogenic potency than other licorice-derived flavonoids (such as isoliquiritin, liquiritigenin and isoliquiritin apioside). 12 Recently, we showed that ISL, at a subtoxic dose of 10 mM, had a higher efficacy in suppression of endothelial cell growth and migration when compared with other herbal chemicals and Avastin. 22 In the present study, we explored the antiangiogenic potential of ISL by various NV models including regulated angiogenesis by chick chlorioallantoic membrane (CAM) assay, deregulated angiogenesis by silver nitrate cauterisation-induced corneal NV, argon laser photocoagulation-induced choroidal NV and ischaemic oxygen-induced retinopathy assays.
METHODS

Drug reagents
Isoliquiritigenin (ISL; C 15 H 12 O 4 ; CAS number: 961-29-5) was purchased from Tauto Biotech (Shanghai, PR China). A stock solution of 50 mM was prepared in dimethyl sulfoxide (DMSO; Sigma, St Louis, Michigan), aliquoted and stored at À208C.
Ex ovo chick chorioallantoic membrane assay
Chick embryo at postfertilisation day 3 was transferred to a sterile dish (100 mm diameter) and placed in a 378C incubator at 60e70% relative humidity. At day 10, the embryo was grafted with collagen-nylon mesh onplants added with recombinant human VEGF-165 (100 ng/ml, Invitrogen, Carlsbad, California) and ISL (2, 10 or 50 mM) or Avastin (1 mg/ml). 23 After 70 h, the growth of blood vessels within the grids of nylon mesh was quantified under stereomicroscopy (Wild MZ8, Leica, Wetzlar, Germany). The vessel index, representing the ratio of number of grids with blood vessels to total number of grids, was obtained. In each chick embryo, a total of six constructs were grafted in regions devoid of blood vessels. Each drug concentration was tested on a minimum of six embryos. Normal saline (0.9% sodium chloride, B. Braun Medical, Bethlehem, Pennsylvania) with 0.01% DMSO served as vehicle control.
Silver nitrate cauterisation-induced corneal neovascularisation model
The holding and experimental protocols were conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and were approved by the Animal Care Committee of The Chinese University of Hong Kong. Female BALB/c mice (age 6e8 weeks) were anaesthetised with an intraperitoneal injection of ketamine (75 mg/kg)/xylazine (7.5 mg/kg) supplemented by topical proparacaine hydrochloride. In all right eyes, central 2 mm corneal epithelium was removed. The corneas were then cauterised by pressing an applicator stick soaked with aqueous solution of 75% silver nitrate/25% potassium nitrate for 8 s prior to thorough rinsing with normal saline. The mice received topical ISL (0.2 to 50 mM) or normal saline (with 0.01% DMSO) four times daily for a total of 14 days (n¼10 each). At day 7 and 14 of treatment, corneal NV progression was imaged under stereomicroscopy. At each time point, a minimum of five mice were sacrificed, and corneas were harvested and fixed in ice-cold acetone, followed by immunostaining using FITC-conjugated monoclonal antimouse CD31 (PECAM) antibody (4 mg/ml, MEC13.3, Santa Cruz Biotech, Santa Cruz, California). After PBS washes, the corneas were flat-mounted with epithelium side facing up and examined under fluorescence microscopy equipped with Spot RT imaging system (Diagnostic Instruments, Sterling Heights, Michigan). The vascular and total corneal areas bordered within the innermost limbal vessel were determined by IMAGE J Analysis software (National Institute of Health) and analysed using one-way analysis of variance.
Argon-laser photocoagulation-induced choroidal neovascularisation assay
Female C57B/L mice (age 6e8 weeks) were anaesthetised, and pupils were dilated with topical 0.5% tropicamide (Alcon). Choroidal NV was induced in both eyes using a green argon laser (532 nm, 100 mm spot, 100 mW, 0.1 s) (Coherent Novus Omni, Laser Lab, Tampas, Florida) through a slit-lamp delivery system of an OcuLight GL Photocoagulator (Iridex, Mountain View, California). Subsequently, five mice received 1 ml of intravitreal ISL (10, 50 or 200 mM) in the right eyes and normal saline with 0.04% DMSO in left eyes. Choroidal NV was monitored on days 4, 7 and 10 by fundus fluorescein angiography using a digital fundus camera (Heidelberg Retinal Angiograph 2, Heidelberg Engineering, Germany). The extent of fluorescein leakage was graded (1e4) by two masked ophthalmologists using a scoring scheme described earleir. 24 Percentage of scoring grades was compared and analysed by one-way analysis of variance. At day 10, retinas were harvested, fixed with neutral buffered 4% paraformaldehyde (Sigma) and stained with Griffonia simplicifolia isolectin-B4 (GSA I-B4)-FITC conjugate (ALX-650-001F-MC05, Enzo Life Sciences International, Farmingdale, New York). The choroidal vascular area of each lesion site was measured by IMAGE J software.
Oxygen-induced retinopathy neovascularisation assay C57BL/6J mouse pups at postnatal day (P) 7 were placed in an airtight chamber with constant 75% O 2 levels for 5 days. When returned to normal air condition at P12, the pups (n¼10 in each group) received intravitreal ISL (1e100 mM, 1 ml injection volume) in the right eyes and normal saline with 0.02% DMSO (as vehicle control) in left eyes. They were sacrificed at P17 and the sclerachoroid-RPE was harvested and fixed for immunofluorescence of GSA I-B4-FITC conjugate. The retinal flat-mounts were examined under fluorescence microscopy, and the vascular area was quantified by IMAGE J. The mean percentages of vascular area were compared and analysed using the Student t test.
Protein expression analysis
Human umbilical vein endothelial cells (HUVEC, CRL-2873, American Type Culture Collection, Manassas, Virginia) were propagated in complete endothelial cell-growth medium (PromoCell GmbH, Heidelberg, Germany) and antibiotics on a gelatin-coated surface. The cells were starved in M199 medium (Invitrogen) with 0.2% fetal bovine serum for 4 h, followed by treatment with ISL and recombinant human VEGF-165 (20 ng/ ml) for 24 h. Cells cultured with complete medium, under starvation, treated with VEGF and Avastin (312 mg/ml) served as controls. Cells were collected and lysed in a radioimmunoprecipitation assay (RIPA) buffer freshly added with complete protease inhibitor cocktail (Roche, Basel, Switzerland) and 1 mM PMSF (Sigma). Soluble proteins were immunoblotted with mouse monoclonal antibody against human VEGF (Santa Cruz), pigment-epithelium-derived factor (PEDF, Millipore) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)-horseradish peroxidase conjugate (Sigma) followed by enhanced chemiluminescence (GE Healthcare). Band intensity was analysed by Quantity One 4.6.2 (BioRad, Hercules, California).
RESULTS
Effect of ISL on chick CAM assay
In saline control onplants, very few vessels were observed among grids, and the vessel index was 0.14860.053 (figure 1A, G). Onplants with 100 ng/ml of VEGF induced increase in vessel number in the collagen matrix, and the vessel index was 0.72260.081 (figure 1B,G) (p<0.001, paired Student t test). This stimulation was reduced by 42% when 1 mg/ml of Avastin was added (vessel index 0.42660.086, p<0.05, paired Student t test) (figure 1C,G). Addition of 2 mM ISL reduced the vessel index by 4% (0.69160.073) (figure 1D,G). Supplementation with 10 and 50 mM ISL suppressed vessel growth by 75% and 82%, respectively (figure 1EF) (p<0.01, compared with VEGF samples, paired Student t test) (figure 1G). Similar results of ISL reducing chick vasculature was observed in the in ovo CAM assay (p<0.05, one-way analysis of variance test).
Effect of ISL on corneal neovascularisation
In injured corneas treated with topical normal saline, corneal blood vessels reached up to about one-half of corneal radius by day 7 (figure 2A, percentage vascular area in figure 2M ) and more than two-thirds of the corneal radius by day 14 ( figure 2N ). Immunofluorescence for CD31 revealed new blood vessels on the avascular central cornea ( figure 2D ). Topical ISL eye-drops were applied four times daily starting immediately after the injury. At day 7, 0.5 mM ISL-treated corneas showed a restriction of growth of new blood vessels (figure 2B, CD31 immunostaining in figure 2E ) (the vascular area was 4368%, compared with 5064% in untreated control) ( figure 2M ). The mean percentage of vascular area was 2463% for 1 mM ISL (figure 2C, CD31 immunostaining in figure 2F ), 1962% for 5 mM ISL ( figure 2G,J) , 1562.5% for 10 mM ISL (figure 2H,K) and 1764% with 50 mM ISL ( figure 2I,L) . The dosage effect of topical ISL on percentage of vascular area is summarised in figure 2M . A similar observation of ISL suppressing the percentage of vascular area was noted on day 14 ( figure 2N ). The effective concentration to produce 50% effect for ISL at day 7 was 7.14 mM, and at day 14 7.39 mM. At both examination time points, the topical ISL at 10 mM was the most effective dose for suppressing corneal NV. We did not observe any cytotoxic effects owing to the topical ISL (up to 50 mM application dose). The mice had normal behaviour with no systemic symptoms (like convulsions, seizures, paralysis, bleeding or death) or ocular symptoms (such as corneal surface redness, swollen eyes, inflammation, ulcers or bleeding).
Argon laser photocoagulation-induced choroidal neovascularisation assay
Intravitreal injection of normal saline with or without ISL was performed immediately after laser photocoagulation. We injected 1 ml of ISL in three doses (10, 50 or 200 mM). Since the volume of vitreous in mouse eye is w10 ml, 25 the effective intravitreal concentrations of ISL achieved were 1, 5 and 20 mM, respectively. At day 4, the control mice exhibited 56% choroidal NV lesions of grade 4 severity on fundus fluorescein angiography (figure 3A,C), whereas 44% exhibited grade 4 lesions on day 7 ( figure 3D ). With intravitreal ISL, reduced leakage was observed even with 10 mM ISL (figure 3B). We observed 11% grade 4 lesions with 50 mM of ISL and none with 200 mM ISL ( figure  3C ).
Choroidal NV in the laser lesions was demonstrated by immunofluorescence with GSA I-B4-FITC conjugate (figure 3EeH). Vascular area quantification showed a reduction in immunopositive area after ISL treatments compared with saline control lesions (39% for 10 mM ISL, 45% for 50 mM ISL and 49% for 200 mM ISL) (n¼5 in each group) (figure 3I).
Oxygen-induced retinopathy neovascularisation assay
We established a mouse model of oxygen-induced retinopathy (OIR). By immunofluorescence using GSA I-B4, the retina showed a typical appearance of ischaemic retinopathy at P17 (figure 4D), when compared with normal retina (figure 4E). We observed that the retinal NV was significantly reduced after intravitreal injection of 10 mM ISL at P12 (figure 4B) but mildly reduced after treatment with 1 and 100 mM ISL ( figure 4A,C) . The mean percentage of OIR-vascular area was 88.665.6% for the saline control group, 8764.8% for 1 mM ISL group, 77.765.8% for 10 mM ISL group and 84.766.8% for 100 mM ISL group (figure 4F). No ISL-caused abnormal behaviour or death of animal was observed.
Expression analysis
HUVECs treated with recombinant human VEGF (20 ng/ml) with or without Avastin (312 mg/ml) or ISL (10 mM) for 24 h were harvested, and RIPA-soluble fractions were analysed for VEGF and PEDF expression by western blotting. Using band densitometry and normalisation with housekeeping GAPDH, we observed reduced VEGF expression in cells under serum-free and growth factor-free starvation (sample 2) when compared with normal culture cells (sample 1) ( figure 5A,B) . Treatment with VEGF/ISL significantly downregulated VEGF level (p<0.005, compared with VEGF only, sample 3, paired Student t test). Similar results were observed for VEGF/Avastin-treated cells (sample 4). However, ISL treatment substantially upregulated PEDF (p<0.005, compared with sample 3, paired Student t test). Meanwhile, dose-dependent changes in both VEGF and PEDF expression were observed with ISL treatment (0 to 50 mM) ( figure 5C ). 
DISCUSSION
Maintenance of avascularity is achieved by a fine balance between antiangiogenic factors such as angiostatin, endostatin or PEDF, and pro-angiogenic factors such as fibroblast growth factor-2, VEGF and hepatocyte growth factor/scatter factor. 26 27 A number of natural herbal extracts or chemicals have been identified for their antiangiogenic, antioxidative and/or antiinflammatory activity. Some of these chemicals possess antitumour and antimetastatic properties. 28e35 In the present study, we reported that ISL markedly and dose-dependently reduced new blood-vessel formation from the pre-existing vasculature. With the ex ovo CAM assay, ISL concentrations up to 50 mM attenuated the growth of new blood vessels in the collagen onplant embedded with 100 ng/ml of recombinant human VEGF-165, and this was more effective than treatment with Avastin (1 mg/ml). HUVEC cells treated with ISL for 24 h had reduced intracellular expression of VEGF and promoted PEDF expression. Topical ISL in mice exhibiting corneal NV resulted in a dose-dependent suppression of new vessels on the corneal surface. Among the tested range of 0.1 to 50 mM, topical ISL at dose of 10 mM showed the most potent antiangiogenic effect in our experiment. In choroidal NV and OIR assays, vascular leakage and the neovascular area decreased respectively with intravitreal ISL treatment. These results are consistent with our in vitro findings. 22 At subcytotoxic levels, ISL suppressed HUVEC proliferation and migration under VEGF stimulation in a scratch-wound model. 22 Unlike corneal NV and choroidal NV results, a dose-dependent response of ISL was not observed in our OIR assay. This variable drug effect could be influenced by the local vitreous environment factors, such as cytokines and growth factors, in the early postnatal mice. Moreover, owing to the small size of the eye in P12 mice (1w2 ml humour volume), the intravitreal injection of 1 ml drug volume might lead to reflux and underestimation of the drug effect. Also, the injection dose of 10 mM ISL in P12 OIR mice would result in an effective concentration of w5 mM. This was comparable with the intraocular dose (w5 mM) in adult mice (reported with w10 ml humour volume) 36 after intravitreal ISL (50 mM) in the laser CNV assay.
ISL is isolated from licorice (G uralensis) and belongs to the family of flavonoids. It has a defined molecular structure (C 15 H 12 O 4 ), which can be modified for its potential applications.
It has been reported to possess anti-inflammatory, antioxidative and antiangiogenic properties. 37 Previous studies have shown that ISL induced apoptosis in colon, gastric and prostate cancer cells.
38e40 It impeded matrix metalloproteinase production and its subsequent activation to restrict endothelial cell motility, 19 37 possibly mediated through inhibition of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. 19 Sheela et al reported that the aqueous extract of licorice effectively inhibited VEGF-induced angiogenesis and microvessel density in the peritoneum of mice. 16 In our HUVEC experiment, ISL 41 42 we have to confirm these effects of ISL on the corneal tissue, which is under way in our laboratory. Moreover, the effect of ISL on VEGF receptor expression on endothelial cells and its effect on VEGF/PEDF expression in extravascular tissues (eg, corneal macrophages, fibroblasts, choroids, and retinal pigment epithelium) needs further investigation. We also found that ISL substantially upregulated PEDF, which was not observed for treatment with Avastin. 43 44 PEDF, a member of the serpin family, regulates cell proliferation and promotes survival of neurons. 45 It is the most potent angiostatic molecules that effectively inhibit new vessel formation and endothelial cell proliferation. 46 In eyes with choroidal NV, the vitreous concentration of PEDF was reported to be lower than that in agematched control eyes. 47 48 PEDF is also an endogenous inflammation inhibitor. Low PEDF levels leading to retinal NV and diabetic macular oedema in diabetic retina might be related to augmented inflammation. 49 Through our systematic approach, we showed an effective suppression of in vivo ocular angiogenesis with ISL. Further studies would help consolidate our findings and highlight the therapeutic potential of ISL for the control of NV in ocular or other systems.
